Literature DB >> 8068835

Flexible maximum likelihood methods for assessing joint effects in case-control studies with complex sampling.

S Wacholder1, C R Weinberg.   

Abstract

Case-control studies can often be made more efficient by using frequency matching, randomized recruitment, stratified sampling, or two-stage sampling. These designs share two common features: (1) some "first-stage" variables are ascertained for all study subjects, while complete variable ascertainment is carried out for only a selected subsample, and (2) the subsampling of subjects for "second-stage" variable ascertainment depends jointly on their disease status and their observed first-stage variables. Because first-stage variables alter the subsampling fractions, standard analyses require a multiplicative specification of any joint effects of a second- and a first-stage variable. We show that by making use of missing data methods, maximum likelihood estimates can be obtained for risk parameters of interest, even those characterizing interactions between first- and second-stage variables. Joint effects can thus be modelled flexibly, with allowance for both additive and multiplicative models. Preliminary data from a case-control study of lung cancer as related to age, sex, and smoking provide an example, leading to the suggestion that the combined effect of age and smoking is multiplicative.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8068835

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration.

Authors:  Til Stürmer; Sebastian Schneeweiss; Jerry Avorn; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

2.  Optimal design for epidemiological studies subject to designed missingness.

Authors:  Michele Morara; Louise Ryan; Andres Houseman; Warren Strauss
Journal:  Lifetime Data Anal       Date:  2007-12-14       Impact factor: 1.588

3.  On semiparametric efficient inference for two-stage outcome-dependent sampling with a continuous outcome.

Authors:  Rui Song; Haibo Zhou; Michael R Kosorok
Journal:  Biometrika       Date:  2009-01-26       Impact factor: 2.445

4.  Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome.

Authors:  Haibo Zhou; Jianwei Chen; Tiina H Rissanen; Susan A Korrick; Howard Hu; Jukka T Salonen; Matthew P Longnecker
Journal:  Epidemiology       Date:  2007-07       Impact factor: 4.822

5.  Statistical inference for a two-stage outcome-dependent sampling design with a continuous outcome.

Authors:  Haibo Zhou; Rui Song; Yuanshan Wu; Jing Qin
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

6.  Associations of red meat, fat, and protein intake with distal colorectal cancer risk.

Authors:  Christina Dawn Williams; Jessie A Satia; Linda S Adair; June Stevens; Joseph Galanko; Temitope O Keku; Robert S Sandler
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

7.  Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer Study.

Authors:  Jessie A Satia; Marilyn Tseng; Joseph A Galanko; Christopher Martin; Robert S Sandler
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

8.  Statistical inferences for data from studies conducted with an aggregated multivariate outcome-dependent sample design.

Authors:  Tsui-Shan Lu; Matthew P Longnecker; Haibo Zhou
Journal:  Stat Med       Date:  2016-12-14       Impact factor: 2.373

9.  Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling.

Authors:  Xiaofei Wang; Haibo Zhou
Journal:  Biometrics       Date:  2009-06-09       Impact factor: 2.571

10.  The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans.

Authors:  Lisa C Vinikoor; Millie D Long; Temitope O Keku; Christopher F Martin; Joseph A Galanko; Robert S Sandler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.